切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2020, Vol. 16 ›› Issue (01) : 74 -80. doi: 10.3877/cma.j.issn.1673-5250.2020.01.010

所属专题: 文献

论著

丙戊酸钠联合左乙拉西坦治疗儿童癫痫的疗效及其对血清S-100β与高迁移率族蛋白-1的影响
李慧敏1, 郝锦丽1, 陈华1, 孟勇2,()   
  1. 1. 内蒙古包钢医院儿科,包头 014010
    2. 河南省新乡医学院第一附属医院小儿外科 453000
  • 收稿日期:2019-11-04 修回日期:2020-01-20 出版日期:2020-02-01
  • 通信作者: 孟勇

Effects of sodium valproate combined with levetiracetam in treatment of children epilepsy and its influences on serum S-100β and high mobility group box-1

Huimin Li1, Jinli Hao1, Hua Chen1, Yong Meng2,()   

  1. 1. Department of Pediatrics, Inner Mongolia Baogang Hospital, Baotou 014010, Inner Mongolia Autonomous Region, China
    2. Department of Pediatric Surgery, Xinxiang Medical University, Xinxiang 453000, Henan Province, China
  • Received:2019-11-04 Revised:2020-01-20 Published:2020-02-01
  • Corresponding author: Yong Meng
  • About author:
    Corresponding author: Meng Yong, Email:
  • Supported by:
    Science and Technology Pillar Project of Science and Technology Department of Henan Province(142300410193)
引用本文:

李慧敏, 郝锦丽, 陈华, 孟勇. 丙戊酸钠联合左乙拉西坦治疗儿童癫痫的疗效及其对血清S-100β与高迁移率族蛋白-1的影响[J/OL]. 中华妇幼临床医学杂志(电子版), 2020, 16(01): 74-80.

Huimin Li, Jinli Hao, Hua Chen, Yong Meng. Effects of sodium valproate combined with levetiracetam in treatment of children epilepsy and its influences on serum S-100β and high mobility group box-1[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2020, 16(01): 74-80.

目的

探讨丙戊酸钠联合左乙拉西坦治疗儿童癫痫(children epilepsy)的疗效,以及对患儿血清S-100β与高迁移率族蛋白(HMGB)-1的影响。

方法

选择2016年7月至2018年10月,在内蒙古包钢医院诊断为儿童癫痫的160例患儿为研究对象。采用随机数字表法,将其随机分为研究组(n=80)与对照组(n=80),对其癫痫发作分别采取丙戊酸钠联合左乙拉西坦治疗与仅用丙戊酸钠的治疗策略。治疗16周后,评价2组患儿癫痫发作治疗有效率及改善脑电图痫样放电治疗有效率,并采用χ2检验进行统计学比较。治疗前、后,对2组患儿炎症相关指标进行检测,包括血清肿瘤坏死因子(TNF)-α,高敏C反应蛋白(hs-CRP),同型半胱氨酸(Hcy)水平及血细胞比容(HCT)与红细胞沉降率(ESR),以及血清S-100β与HMGB-1水平。对上述指标治疗前、后组内比较,采用配对t检验;组间比较,采用成组t检验。2组患儿治疗过程中不良反应率比较,采用χ2检验。本研究遵循的程序符合内蒙古包钢医院伦理委员会要求,并获得批准(审批文号:BG201606073),与所有受试儿监护人签署临床研究知情同意书。2组患儿性别构成比、年龄、病程、治疗前癫痫每年发作次数、治疗前脑电图痫样放电发生率及癫痫发作类型构成比等一般临床资料比较,差异均无统计学意义(P>0.05)。

结果

①治疗后,研究组患儿癫痫发作的治疗有效率、改善脑电图痫样放电治疗有效率分别为92.5%(74/80)与85.0%(68/80),显著优于对照组的68.8%(55/80)与58.8%(47/80),并且差异均有统计学意义(χ2=14.444、13.635,P<0.001)。②治疗后,研究组患儿的血清TNF-α、hs-CRP、Hcy水平及HCT与ESR分别为(53.1±14.0)pg/mL、(5.0±2.5)mg/L、(12.5±3.1)μmol/L、(38.1±5.1)%与(3.0±0.5)mm/h,显著低于其治疗前的(107.9±17.8)pg/mL、(10.1±2.5)mg/L、(42.2±5.8)μmol/L、(45.3±4.5)%与(5.2±0.6)mm/h,并且差异均有统计学意义(t=21.644、12.902、40.393、9.468、25.194,P<0.001);对照组患儿的血清TNF-α、hs-CRP、Hcy水平及HCT与ESR分别为(60.6±17.8)pg/mL、(8.2±2.2)mg/L、(15.2±3.1)μmol/L、(40.2±3.4)%与(4.5±0.6)mm/h,显著低于其治疗前的(112.4±14.3)pg/mL、(9.3±3.8)mg/L、(41.1±2.8)μmol/L、(44.6±5.5)%与(5.4±0.8)mm/h,并且差异均有统计学意义(t=20.292、2.241、55.456、3.320、8.050,P<0.05)。治疗后组间比较,研究组患儿的上述指标均显著低于对照组,并且差异均有统计学意义(t=2.962、8.595、5.508、3.064、17.178,P<0.05)。③治疗后,研究组患儿的血清S-100β与HMGB-1水平分别为(0.65±0.38)μg/L与(5.3±2.4)μg/L,显著低于治疗前的(0.91±0.32)μg/L与(8.1±2.0)μg/L,并且差异均有统计学意义(t=4.681、8.020,P<0.001);对照组患儿的血清S-100β与HMGB-1水平分别为(0.78±0.27)μg/L与(6.4±2.2)μg/L,显著低于治疗前的(0.88±0.25)μg/L与(7.9±1.7)μg/L,并且差异均有统计学意义(t=2.431、P=0.016,t=4.826、P<0.001)。治疗后,研究组患儿的上述指标,均显著低于对照组,并且差异均有统计学意义(t=2.495、P=0.014,t=2.840、P=0.005)。④2组患儿治疗过程中恶心呕吐、纳差、头晕、嗜睡及肝、肾功能损伤等不良反应率比较,差异无统计学意义(P>0.05)。

结论

丙戊酸钠联合左乙拉西坦治疗癫痫患儿的疗效,显著优于仅用丙戊酸钠者,而且患儿血清S-100β及HMGB-1降低更显著,导致的不良反应率更低,具有一定临床应用价值。

Objective

To explore the effects of sodium valproate combined with levetiracetam in treatment of children epilepsy, and influences of treatment on serum S-100β and high mobility group box (HMGB)-1 in children with epilepsy.

Methods

A total of 160 children who were diagnosed as epilepsy in Inner Mongolia Baogang Hospital from July 2016 to October 2018 were selected as research subjects, and they were randomly sorted into study group (n=80) and control group (n=80) by random digits table method. Their seizures were treated with sodium valproate combined with levetiracetam and sodium valproate alone, respectively. After 16 weeks of treatment, the effective rates of seizure disorder treatment and improvement of epileptiform discharge of electroencephalography were evaluated, and chi-square test was used for statistical comparison. Levels of serum tumor necrosis factor (TNF)-α, hyper sensitive C-reactive protein (hs-CRP) and homocysteine (Hcy), and hematocrit (HCT) and erythrocyte sedimentation rate (ESR), and the levels of serum S-100β and HMGB-1 were detected before and after treatment. Paired-samples t test was used for intra-group comparison before and after treatment among the above indexes, independent-samples t test was used for inter-group comparison. Chi-square test was used to compare the rate of adverse reactions during treatment between two groups. The study was approved by the Ethics Committee of Inner Mongolia Baogang Hospital (Approval No. BG201606073), and all guardians of children signed the informed consent forms for clinical study. There were no significant differences between two groups in general clinical data, such as gender constituent ratio, age, course of disease, frequency of seizure disorder per year before treatment, incidence of epileptiform discharge of electroencephalography and constituent ratio of epileptiform discharge types before treatment, etc. (P>0.05).

Results

①The effective rate of seizure disorder treatment and improvement of epileptiform discharge of electroencephalography in study group were 92.5% (74/80) and 85.0% (68/80), respectively, which both were significantly higher than those in control group 68.8% (55/80) and 58.8% (47/80), and both the differences were statistically significant (χ2=14.444, 13.635; P<0.001). ②In study group, the levels of serum TNF-α, hs-CRP and Hcy, and HCT and ESR after treatment were (53.1±14.0) pg/mL, (5.0±2.5) mg/L, and (12.5±3.1) μmol/L, (38.1±5.1)% and (3.0±0.5) mm/h, respectively, which all were significantly lower than (107.9±17.8) pg/mL, (10.1±2.5) mg/L, (42.2±5.8) μmol/L, (45.3±4.5)% and (5.2±0.6) mm/h before treatment, and all the differences were statistically significant (t=21.644, 12.902, 40.393, 9.468, 25.194; P<0.001). In control group, the levels of serum TNF-α, hs-CRP and Hcy, and HCT and ESR after treatment were (60.6±17.8) pg/mL, (8.2±2.2) mg/L, (15.2±3.1) μmol/L, (40.2±3.4)% and (4.5±0.6) mm/h, respectively, which all were significantly lower than (112.4±14.3) pg/mL, (9.3±3.8) mg/L, (41.1±2.8) μmol/L, (44.6±5.5)% and (5.4±0.8) mm/h before treatment, and all the differences were statistically significant (t=20.292, 2.241, 55.456, 3.320, 8.050; P<0.05). After treatment, the above indexes in study group all were statistically lower than those in control group, and all the differences were statistically different (t=2.962, 8.595, 5.508, 3.064, 17.178; P<0.05). ③In study group, levels of serum S-100β and HMGB-1 after treatment were (0.65±0.38) μg/L and (5.3±2.4) μg/L respectively, which were significantly lower than those before treatment (0.91±0.32) μg/L and (8.1±2.0) μg/L, and both the differences were statistically significant (t=4.681, 8.020; P<0.001). In control group, levels of serum S-100β and HMGB-1 after treatment were (0.78±0.27) μg/L and (6.4±2.2) μg/L respectively, which were significantly lower than those before treatment (0.88±0.25) μg/L and (7.9±1.7) μg/L, and both the differences were statistically significant (t=2.431, P=0.016; t=4.826, P<0.001). After treatment, levels of serum S-100β and HMGB-1 in study group were significantly lower than those in control group, and both the differences were statistically significant (t=2.495, P=0.014; t=2.840, P=0.005). ④There was no significant difference between two groups in rate of adverse reactions, such as nausea, vomiting, anorexia, dizziness, drowsiness, liver and kidney injury during treatment (P>0.05).

Conclusions

The efficacy of sodium valproate combined with levetiracetam is obviously better than that of sodium valproate alone in treatment of children with epilepsy. The children′s serum S-100β and HMGB-1 are more significantly reduced, resulting in a lower rate of adverse reactions, which has certain clinical values.

表1 2组癫痫患儿的临床资料比较
表2 治疗后,2组癫痫患儿癫痫发作情况及脑电图痫样放电改善情况比较[例数(%)]
表3 2组癫痫患儿血清TNF-α、hs-CRP、Hcy水平与HCT及ESR比较(±s)
表4 2组癫痫患儿血清S-100β与HMGB-1水平比较(μg/L,±s)
表5 2组患儿治疗过程中不良反应发生情况比较[例数(%)]
[1]
Ferro MA, Avery L, Fayed N, et al. Child- and parent-reported quality of life trajectories in children with epilepsy: a prospective cohort study[J]. Epilepsia, 2017, 58(7): 1277-1286. DOI: 10.1111/epi.13774.
[2]
Auvin S. Advancing pharmacologic treatment options for pharmacologic treatment options for children with epilepsy[J]. Expert Opin Pharmacother, 2016, 17(11): 1475-1482. DOI: 10.1080/14656566.2016.1195809.
[3]
Weijenberg A, Brouwer OF, Callenbach PM. Levetiracetam monotherapy in children with epilepsy: a systematic review[J]. CNS Drugs, 2015, 29(5): 371-382. DOI: 10.1007/s40263-015-0248-9.
[4]
Meguid NA, Samir H, Bjørklund G, et al. Altered S100 calcium-binding protein B and matrix metallopeptidase 9 as biomarkers of mesial temporal lobe epilepsy with hippocampus sclerosis[J]. J Mol Neurosci, 2018, 66(4): 482-491. DOI: 10.1007/s12031-018-1164-5.
[5]
Zhu M, Chen J, Guo H, et al. High mobility group protein b1 (HMGB1) and interleukin-1β as prognostic biomarkers of epilepsy in children[J]. J Child Neurol, 2018, 33(14): 909-917. DOI: 10.1177/0883073818801654.
[6]
中华医学会儿科学分会神经学组. 新诊断儿童癫痫的初始单药治疗专家共识[J]. 中华儿科杂志,2015, 53(10): 734-737. DOI: 10.3760/cma.j.issn.0578-1310.2015.10.006.
[7]
张利利,程亚颖. 左乙拉西坦与丙戊酸钠对小儿癫痫认知功能的影响比较[J]. 西北国防医学杂志,2016, 37(5): 346-347. DOI: 10.16021/j.cnki.1007-8622.2016.05.02.
[8]
A Yassine I, M Eldeeb W, A Gad K, et al. Cognitive functions, electroencephalographic and diffusion tensor imaging changes in children with active idiopathic epilepsy[J]. Epilepsy Behav, 2018, 84: 135-141. DOI: 10.1016/j.yebeh.2018.04.024.
[9]
Perucca P, Scheffer IE, Kiley M. The management of epilepsy in children and adults[J]. Med J Aust, 2018, 208(5): 226-233. DOI: 10.5694/mja17.00951.
[10]
Akter N, Rahman MM, Akhter S, et al. A randomized controlled trial of phenobarbital and levetiracetam in childhood epilepsy[J]. Mymensingh Med J, 2018, 27(4): 776-784. DOI: 10.1136/ijgc-2018-000962.
[11]
李香丹,李今子,高帆,等. 癫痫相关标志物的研究进展[J]. 山东医药,2018, 58(19): 108-111. DOI: 10.3696/j.issn.1002-266X2018.19.034.
[12]
Nevitt SJ, Marson AG, Weston J, et al. Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review[J]. Cochrane Database Syst Rev, 2018, 8: CD001769. DOI: 10.1002/14651858.CD001769.pub4.
[13]
邬刚,吴海燕,许虹,等. 左乙拉西坦与丙戊酸钠用于颞叶癫痫添加治疗的疗效对比[J]. 中国医院药学杂志,2018, 38(18): 1953-1956. DOI: 10.13286/j.cnki.chinhospharmacyj.2018.18.16.
[14]
Chen WZ, Tan Y, Ge YX, et al. The effects of levetiracetam on cerebrospinal fluid and plasma NPY and GAL, and on the components of stress response system, hs-CRP, and S100B protein in serum of patients with refractory epilepsy[J]. Cell Biochem Biophys, 2015, 73(2): 489-494. DOI: 10.1007/s12013-015-0683-8.
[15]
苏绮璇,侯小兵. 左乙拉西坦对癫痫患者血清细胞因子及认知状态相关指标的影响[J]. 海南医学,2017, 28(22): 3648-3651. DOI: 10.3969/j.issn.1003-6350.2017.22.011.
[16]
Asadollahi M, Simani L. The diagnostic value of serum UCHL-1 and S100-B levels in differentiate epileptic seizures from psychogenic attacks[J]. Brain Res, 2019, 1704: 11-15. DOI: 10.1016/j.brainres.2018.09.028.
[17]
Liu AH, Wu YT, Wang YP. MicroRNA-129-5p inhibits the development of autoimmune encephalomyelitis-related epilepsy by targeting HMGB1 through the TLR4/NF-kB signaling pathway[J]. Brain Res Bull, 2017, 132: 139-149. DOI: 10.1016/j.brainresbull.2017.05.004.
[1] 陶宏宇, 叶菁菁, 俞劲, 杨秀珍, 钱晶晶, 徐彬, 徐玮泽, 舒强. 右心声学造影在儿童右向左分流相关疾病中的评估价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 959-965.
[2] 刘琴, 刘瀚旻, 谢亮. 基质金属蛋白酶在儿童哮喘发生机制中作用的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 564-568.
[3] 向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[4] 王雅楠, 刘丹, 曹正浓, 贾慧敏. 儿童迟发性先天性膈疝患儿的临床诊治特点分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 410-419.
[5] 刘冉佳, 崔向丽, 周效竹, 曲伟, 朱志军. 儿童肝移植受者健康相关生存质量评价的荟萃分析[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 302-309.
[6] 丁荷蓓, 王珣, 陈为国. 七氟烷吸入麻醉与异丙酚静脉麻醉在儿童腹股沟斜疝手术中的应用比较[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 570-574.
[7] 曾纪晓, 徐晓钢, 王欣星, 刘斐, 兰梦龙, 陶波圆, 梁子建, 叶志华, 罗媛圆. 达芬奇机器人辅助Swenson-like巨结肠根治术[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(04): 239-243.
[8] 中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[9] 刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
[10] 张佳臣, 宋红欣. 儿童青少年等效球镜屈光度变化与屈光不正进展相关性的临床研究[J/OL]. 中华眼科医学杂志(电子版), 2024, 14(04): 217-222.
[11] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
[12] 杨卫东, 周威, 向洪涛. 慢性萎缩性胃炎患者幽门螺杆菌感染与炎性细胞因子及病理特征的关系[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 459-464.
[13] 王晓瑜, 郭群英, 牛雅萌, 赵成松. 公立儿童医院促进儿科就医均等化实践探析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 383-387.
[14] 陈晓胜, 何佳, 刘方, 吴蕊, 杨海涛, 樊晓寒. 直立倾斜试验诱发31 秒心脏停搏的植入心脏起搏器儿童一例并文献复习[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 488-494.
[15] 曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.
阅读次数
全文


摘要